This is cross-posted at my economics blog.
The President's Council of Advisors on Science and Technology has released a report stating that our current clinical trials system is inefficient at producing new medicines for patients. No kidding! But it's at least a step forward for such a body to officially recognize that this innovation bottleneck exists. Here is one proposal for amending the system; it's not the only one, but this is a conversation that needs to be more prevalent.